AHA Scientific Statement Triglycerides and Cardiovascular Disease A Scientific Statement From the American Heart Association

Michael Miller, MD, FAHA, Chair; Neil J. Stone, MD, FAHA, Vice Chair;Christie Ballantyne, MD, FAHA; Vera Bittner, MD, FAHA; Michael H. Criqui, MD, MPH, FAHA;Henry N. Ginsberg, MD, FAHA; Anne Carol Goldberg, MD, FAHA; William James Howard, MD;Marc S. Jacobson, MD, FAHA; Penny M. Kris-Etherton, PhD, RD, FAHA;Terry A. Lennie, PhD, RN, FAHA; Moshe Levi, MD, FAHA; Theodore Mazzone, MD, FAHA;Subramanian Pennathur, MD, FAHA; on behalf of the American Heart Association Clinical Lipidology,Thrombosis, and Prevention Committee of the Council on Nutrition, Physical Activity, and Metabolism,Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiovascular Nursing,and Council on the Kidney in Cardiovascular Disease